Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

The prostate cancer diagnosis of former President Joe Biden is bringing new focus on a disease which claims the lives of around 5,000 Californians a year. And members of the Yolo Prostate Cancer ...

INDIANAPOLIS (WISH) — Prostate cancer remains a significant health concern, being the second leading cause of death among men, particularly affecting black men. Early detection of prostate cancer is ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden.

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.